title: An analysis of content in comprehensive cancer control plans that address chronic hepatitis B and C virus infections as major risk factors for liver cancer.
abstract: Chronic hepatitis B and hepatitis C virus (HBV and HCV) infections are among the leading causes of preventable death worldwide. Chronic viral hepatitis is the cause of most primary liver cancer, which is the third leading cause of cancer deaths globally and the ninth leading cause of cancer deaths in the United States. The extent to which comprehensive cancer control (CCC) programs in states, tribal governments and organizations, territories, and Pacific Island jurisdictions address chronic hepatitis B and/or hepatitis C infections as risk factors for liver cancer or recommend interventions for liver cancer prevention in their CCC plans remains unknown. We searched CCC plans for this information using the search tool at                             http://www.cdc.gov/cancer/ncccp/                                                      to access the content of plans for this information. A combination of key search terms including "liver cancer", "hepatitis", "chronic alcohol", and "alcohol abuse" were used to identify potential content regarding liver cancer risk factors and prevention. Relevant content was abstracted for further review and classification. Of 66 (Although CDC funds 65 programs, one of the Pacific Island Jurisdiction grantees is the Federated States of Micronesia (FSM). This national program supports four FSM states, each of which submits a cancer plan to CDC for a total of 69 plans. During this time period, 66 plans were available on the website.) CCC plans, 27% (n = 18) addressed liver cancer using the above-mentioned search terms. In the 23 plans that addressed HBV and/or HCV, there were 25 goals, objectives, strategies, and outcomes aimed at reducing the incidence or prevalence of HBV and/or HCV infection. While nearly a third of CCC programs identify at least one goal, objective, strategy, outcome, or prevention program to reduce cancer burden in their CCC plans, few plans discuss specific actions needed to reduce the burden of liver cancer.
authors.affiliation: Division of Cancer Prevention and Control, Centers for Disease Prevention and Control, Atlanta, GA 30341, USA. fqv6@cdc.gov
authors.forename: Behnoosh
authors.initials: B
authors.lastname: Momin
authors.forename: Lisa
authors.initials: L
authors.lastname: Richardson
mesh_terms: D003191:Comprehensive Health Care / Q000458:organization & administration*; D019694:Hepatitis B, Chronic / Q000150:complications* / Q000517:prevention & control; D006526:Hepatitis C / Q000150:complications* / Q000517:prevention & control; D006801:Humans; D008113:Liver Neoplasms / Q000517:prevention & control* / Q000821:virology; D009937:Organizational Objectives; D012307:Risk Factors; D014481:United States